Interim GPHA National Programs Coordinator

Dr. Aniwaa Owusu Obeng is a faculty member of the Charles Bronfman Institute for Personalized Medicine and an Assistant Professor in the Departments of Medicine and Genetics and Genomics Sciences at the Icahn School of Medicine at Mount Sinai (ISMMS) in New York, USA. She also has an appointment in The Mount Sinai Hospital as the Senior Director of Pharmacy of the Pharmacogenomic Program. She was previously the Clinical Pharmacogenomics Coordinator. Dr. Obeng joined Mount Sinai in July 2013 and has been spearheading clinical pharmacogenomics implementation efforts in Mount Sinai’s outpatient clinics ever since.

As part of this initiative, physicians are trained to use genetic information to inform their prescribing decisions for approximately 2000 preemptively genotyped patients and counting. She has also led the development of provider and patient educational materials and tools on pharmacogenomics as part of this effort. Moreover, Dr. Owusu Obeng directs clinical pharmacogenomics rotations for PGY1 and PGY2 pharmacy residents in the Mount Sinai Health System and Advanced Pharmacy Practice Experience (APPE) rotation for final year student pharmacists.

Dr. Owusu Obeng obtained her Doctor of Pharmacy degree from the Albany College of Pharmacy and Health Sciences in Albany, NY. She then pursued a clinical residency (PGY1) in general pharmacy practice at the Bronx- Lebanon Hospital Center in Bronx, NY, and subsequently, PGY2 at the University of Florida College of Pharmacy and UF Health Shands Hospital in Gainesville, Florida. As the inaugural resident in the UF Health Personalized Medicine Program, Dr. Owusu Obeng specialized in Pharmacogenomics and Drug Information.

Dr. Obeng has published over 30 peer-reviewed manuscripts and book chapters on pharmacogenomics and precision medicine. She is a guideline writing member of the Clinical Pharmacogenetics Implementation Consortium (CPIC); member of the Pharmacogenomics Working Group in the NIH/NHGRI – funded IGNITE (Implementing Genomics in Practice) Network; 2017 ISMMS Leadership Emerging in Academic Departments (LEAD) Scholar; and a member and 2017 MERIT Scholar of the American College of Clinical Pharmacy (ACCP).

Her research interests mainly lie in bridging the gap between discovery of genetic determinants of therapeutic response and clinical implementation by developing best practice processes to effectively adopt genomic medicine into everyday clinical practice.